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Incubation of 1321N1 human  astrocytoma  cells  with 
1 PM isoproterenol  rapidly  results in  the conversion of 
a portion of the  &adrenergic  receptors  to a membrane 
form that can be separated from markers for the 
plasma  membrane  by  sucrose  density  gradient or dif- 
ferential  centrifugation.  This  “light  peak”  form of the 
receptor reaches a maximal level within 10 min of 
incubation of cells with catecholamine. Two  types of 
experiments  suggest  that  the  early  phase of catechol- 
amine-induced  desensitization of the  @-adrenergic re- 
ceptor-linked  adenylate  cyclase  can be separated  into 
at  least  two  reactions.  First,  the  agonist-induced loss 
of catecholamine-stimulated  adenylate  cyclase  activity 
precedes the  appearance of &adrenergic  receptors  in 
the  light  peak  fraction by 1-2 min. Second, pretreat- 
ment of cells with  concanavalin A prior  to  induction of 
desensitization  blocks the formation of the  light  peak 
form of &adrenergic  receptors  without  blocking  the 
“uncoupling”  reaction as measured  by  catecholamine- 
stimulated adenylate cyclase activity. Specificity for 
the reaction that converts &adrenergic receptors to 
the  light  peak  form  is  indicated by the  lack of a cate- 
cholamine-induced alteration in the sucrose density 
gradient  distribution of muscarinic  cholinergic  recep- 
tors,  adenylate cyclase or  the  guanine nucleotide-bind- 
ing proteins, N. and Ni. The  light  peak of &adrenergic 
receptors  migrates at  a density  similar  to  that of at 
least a portion of the  activity of galactosyltransferase, 
a marker  for Golgi. Enzyme marker  activities  for ly- 
sosomes and endoplasmic  reticulum are not  associated 
with  this population of &adrenergic  receptors.  Taken 
together,  these  and  other  data suggest that incubation 
of 1321N1 cells with  isoproterenol  results  in a rapid 
uncoupling of @-adrenergic  receptors  from  adenylate 
cyclase  which is followed by a change  in  the  membrane 
form of the  receptor.  This  latter step most likely rep- 
resents internalization of receptors into a vesicular 
form  which  may then  serve as the  precursor  state  from 
which  receptors are eventually  lost  from  the cell. 
Agonist-induced desensitization of the @-adrenergic  recep- 
tor-linked  adenylate cyclase of human  astrocytoma (1321N1) 
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cells has been  shown to involve a t  least two reactions (1-3). 
First, cells exposed to  catecholamines experience  a rapid (t l lS - 2 min)  functional uncoupling of receptors from adenylate 
cyclase which is expressed as a 50% decrease  in the respon- 
siveness of the enzyme to agonists  and a loss of capacity of 
agonists  to  form a  high affinity  binding complex (1 ,3) .  These 
alterations  are rapidly ( tl /* - 7 min)  and completely  reversible 
upon  removal of catecholamine from the medium  (3). A 
second reaction that results in the loss of radiolabeled 6- 
adrenergic receptor  antagonist  binding occurs after a lag of 
30-60 min (2-4); the  formation  and  rate of recovery of lost 
receptors is much slower than  the  changes occurring during 
short-term exposure of cells to  agonist (3 ,4) .  Similar  phenom- 
ena  have been shown  to occur in a variety of other cell types 
during exposure to  catecholamines (5-9). 
We have reported recently that  short-term  incubation of 
1321N1 cells with  isoproterenol also  results  in  the accumula- 
tion of a subpopulation of receptors that exhibits altered 
sedimentation properties on sucrose density gradients (10). 
The  time course of appearance of this  population of receptors 
roughly coincided  with the  agonist-induced uncoupling reac- 
tion.  Furthermore,  the agonist binding  properties of this  re- 
ceptor  population were equivalent  to  that of “uncoupled” p- 
adrenergic  receptors. Exposure of frog erythrocytes  to  cate- 
cholamines  results  in  the  appearance of a similar  subpopula- 
tion of @-adrenergic receptors in supernatant fractions of 
lysates (11-13). We describe in  the  present  report  results from 
experiments that further characterize the agonist-induced 
modification of the  membrane  form of the  6-adrenergic recep- 
tor  in  1321N1  astrocytoma cells. 
EXPERIMENTAL PROCEDURES“’ 
UalWLal. 
The follov~ns comooundr were obfalned from S c m a  (Sf. Lours, UQ: arnmonlum molybdate,  
“Experimental Procedures” are presented in miniprint as pre- 
pared by the authors. Miniprint is easily read with the aid of a 
standard magnifying glass. Full size photocopies are available from 
the  Journal of Biological Chemistry, 9650 Rockville Pike,  Bethesda, 
MD 20814. Request  Document No. 83M-1278, cite  the  authors,  and 
include a check or money order for $2.00 per  set of photocopies.  Full 
size photocopies are also included in the microfilm edition of the 
Journal  that is available  from  Waverly Press. 
‘The abbreviations are: ConA, concanavalin A; Hepes, 4-(2-hy- 
droxyethy1)-1-piperazineethanesulfonic acid; ‘*‘I-PIN, (-)-1251-pin- 
dolol; [3H]QNB,  (-)-[”H]quinuclidinyl benzilate; IAP,  islet-activating 
protein; N., the  stimulatory  guanine nucleotide  regulatory component 
of adenylate cyclase; Ni, the  inhibitory  guanine nucleotide  regulatory 
component of adenylate cyclase; C, the  catalytic  component of ade- 
nylate cyclase; EGTA,  ethylene glycol bis(P-aminoethyl  ether)- 
N,N,N’,N’-tetraacetic acid; GTPrS,  guanosine 5’-3(thio)triphos- 
phate. 
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RESULTS 
As we have previously reported (lo), short-term (15 min) 
incubation of 1321N1 cells with isoproterenol results in an 
alteration in the distribution of P-adrenergic receptors on 
sucrose density gradients (Fig. 1). Rather than migrating 
principally as a  single peak at a density  equivalent  to  that of 
other  markers of the  plasma  membrane, a large portion of the 
receptors  migrate as a  "light  peak" a t  sucrose densities of 30% 
or less. The  properties of these  light peak receptors have  been 
compared  to  those of receptors  from the  plasma  membrane 
fraction  and from cell lysates. Saturation  binding  isotherms 
for "'I-PIN were generated with receptors from the light  peak 
and from the plasma membrane fraction. Scatchard plots 
were consistent  with a single binding  site in the light peak 
and  the  plasma  membrane  fraction derived  from both  control 
and desensitized cultures (Fig. 2).  The affinity (12-15 PM) of 
"'I-PIN in  each  receptor-containing  fractirn was similar to 
that (14 PM) determined in cell lysates (data  not  shown). 
The kinetics of I2'II-PIN binding also were examined for 
each receptor  fraction.  The  rate  constants for  association ( k , )  
of '"I-PIN were 8.4 X los, 8.3 X lo*, and 11.7 X 10' M" min" 
for the  control ysate,  desensitized light peak, and desensitized 
plasma  membrane  fraction, respectively. The  rate  constants 
for  dissociation (k , )  were 0.015,0.031, and 0.021 min" for the 
same  three  receptor-containing  fractions.  The kinetically  de- 
termined dissociation constants (k , /k , )  were in good agree- 
ment with the KIj values determined by equilibrium  assay. 
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FIG. 1. Catecholamine-induced alteration in the sucrose 
density gradient distribution of &adrenergic receptors. Cells 
were incubated in the absence of isoproterenol for 11 h (0) or in the 
presence of 1 p M  isoproterenol for 0.25 (o), 1.5 (A), 4.0 (n), or 11.0 
(V) h.  Following exposure to drug, the cells were treated with ConA 
and lysed as described under "Experimental Procedures." Lysates 
were layered on a sucrose density gradient and centrifuged for 1 h at 
114,000 X g. The gradients used in this experiment (linear sucrose 
running from 30 to 55% (28 ml) above a 2-ml cushion of 60% sucrose) 
were somewhat different than  the gradients used elsewhere (e.g. Figs. 
4 and 7) for resolution of light peak receptors and the plasma 
membrane fraction (see "Experimental Procedures"). Two-ml frac- 
tions were collected from the top. Values were normalized to the 
amount of protein added to each gradient. The  data are representive 
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FIG. 2. Scatchard  analyses of 12SI-PIN binding  to  receptors 
in the  light  peak and plasma  membrane  fractions. Cells were 
incubated in the absence or presence of 1 p~ isoproterenol (ISO) for 
15 min. Lysates from nine 150-mm dishes for each condition were 
then prepared and centrifuged  on  a  continuous 30-60% sucrose 
gradient as described under “Experimental Procedures.” The light 
peak (0) and plasma  membrane (A) fractions of control and desen- 
sitized gradients  each were pooled and diluted with 1 mM Tris  (pH 
7.4 at  4 “C)  and pelleted by centrifugation for 60 min at  170,000 X g 
in a  Beckman 42.1 Ti rotor. The pellets were diluted  with 145 mM 
NaC1, 20 mM Tris  (pH 7.5 at  25 “ C ) ,  and 5 mM MgC12, and specific 
binding of ‘2511-PIN was measured  as  a  function of ligand concentra- 
tion (3-300 PM) at  a protein concentration of approximately  15 pg/ 
assay. 
Although the  total  number of receptors  is only  minimally 
reduced3 during short-term (20 min) incubation of 1321N1 
cells with  isoproterenol (1-3), as we have previously  described 
in  detail,  extended  incubation  results  in a marked reduction 
in  measurable  receptors (2-4). Thus,  the  temporal  relation- 
ship of receptors  appearing  in  the  light  peak  to  those  in  the 
plasma  membrane  fraction was examined.  Maximal conver- 
sion of receptors  to  the  light  peak form  occurred within 10 
min during  incubation of cells with 1.0 FM isoproterenol.  Once 
Over a  5-year period, some variability in the degree of receptor 
loss during short-term exposure of  1321N1 cells to 1 p~ isoproterenol 
has occurred. Although receptor levels in lysates from cells pretreated 
for 20 min with catecholamine are usually 90-100% of control, in 
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FIG. 3. Temporal  relationship of catecholamine-induced 
loss of hormone-stimulated  adenylate cyclase activity to the 
conversion of &receptors to the altered membrane form. Four 
150-mm dishes of 1321N1 cells were used per time point. Ten-ml 
aliquots of Hepes-buffered Eagle’s medium containing 1 p~ isopro- 
terenol were warmed to 37 “C. The growth medium was aspirated 
from all dishes, and incubations were initiated by rapidly pouring the 
isoproterenol-containing medium onto  the dishes and placing them 
in an incubator at  37 “C. Reactions were terminated by the rapid 
aspiration of the desensitization medium and immediate  addition  on 
ice of ice-cold Hepes-buffered Eagle’s medium containing 0.25 mg/ 
ml of ConA. Dishes were then placed on ice for 20 min, followed  by 
hypotonic lysis as described earlier. Aliquots of the lysates were saved 
for determination of isoproterenol  (10  pM)-stimulated  adenylate cy- 
clase activity (O), and  the remaining  lysate was layered on a 30-60% 
sucrose gradient and centrifuged as described under  “Experimental 
Procedures.” The specific binding of Iz5I-PIN (0) in  the light peak 
fractions was summed and plotted as a  per  cent of maximal activity. 
Isoproterenol-stimulated  adenylate cyclase activity  is  plotted as  the 
per  cent of activity in control lysates. The  data is the mean & S.E. of 
four experiments. 
a maximal conversion of receptors to the light peak form 
occurred, receptors were lost from this  and  the  plasma  mem- 
brane fraction with similar time courses (Fig. 1). Thus, a 
precursor-product relationship could not be established di- 
rectly for the light peak form of receptors in generating 
receptors  that  are  lost from the cell. 
The appearance of receptors in the light peak fraction 
occurs during a time when a major decrement in catechol- 
amine-stimulated  adenylate cyclase activity occurs. Thus,  at- 
tempts were made to  define  in  detail  the  temporal  relationship 
between the  change  in  the  membrane  form of P-adrenergic 
receptors  and  the uncoupling of adenylate cyclase as measured 
by a loss of isoproterenol-stimulated enzyme  activity. As we 
have  previously reported (3), catecholamine-stimulated  ade- 
nylate cyclase activity  is rapidly lost ( t 1 / 2  = 2.5 min)  during 
incubation of cells with isoproterenol  to a level that  is  ap- 
proximately 50% of control (Fig. 3). Although catecholamine- 
stimulated  activity was reduced by 20-25% during  the first 1- 
2 min of incubation  with isoproterenol (Fig. 3 and Ref. 3), no 
significant change (p > 0.05) occurred in the number of 
receptors  appearing  in  the  light peak (Fig. 3). After  this lag 
of 1-2 min, a conversion of P-adrenergic  receptors to  the light 
peak form occurred,  with maximal levels of receptor appearing 
in this  fraction  within 10 min (t112 - 4.5 rnin). 
Such  kinetic  experiments (Fig. 3) indicated  that,  at  least  at 
very short times of incubation, the uncoupling reaction as 
measured by isoproterenol-stimulated  adenylate cyclase activ- 
ity could be distinguished  from  the  change  in  the  membrane 
form of receptors. This distinction was pursued further by 
examining the effects of various chemicals on these two 
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FIG. 4. Effect  of  ConA  on  agonist- 
induced changes in catecholamine- 
stimulated  adenylate  cyclase  activ- 
ity and the membrane form of 8- 
adrenergic  receptors. Left, cells were 
preincubated for 45 min at  37 “C with 
Hepes-buffered Eagle’s medium with (0) 
or without (0 and A) 250 Fg/ml of ConA. 
Isoproterenol (1 FM) was then added to 
two sets (0 and A) of the cultures, and 
the incubation was continued for an- 
other 20 min. The medium was then 
aspirated, and all cultures were treated 
with ConA and gradients generated as 
described under “Experimental Proce- 
dures.” The data are representative of 
six experiments. Right, isoproterenol- 
stimulated adenylate cyclase activity was 
determined in lysates from cells treated 
with ConA and/or isoproterenol (15’0) 
as described for the left panel of this 
figure. The  data  are xpressed as  the  per 
cent of the value for isoproterenol-stim- 
ulated  activity divided by basal  activity 
for control cells. The  data  are  the mean 
t S.E. for four  experiments. 
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processes. Preincubation of cells with 0.25 mg/ml of ConA4 
for 30-45 min at 37 “C  prior  to  incubation with  isoproterenol 
completely  blocked the  agonist-induced conversion of recep- 
tors  to  the  light  peak  form (Fig. 4).  In  contrast,  the loss of 
isoproterenol-stimulated  adenylate cyclase activity  in ConA- 
pretreated cells was the  same  as in control cells (Fig. 4).  Thus, 
as suggested  by the  kinetic  experiments,  the agonist-induced 
uncoupling of the @-adrenergic  receptor-linked  adenylate cy- 
clase apparently  can occur without  the  change  in  the  mem- 
brane  form of @-adrenergic receptors. The effect of ConA on 
recovery from catecholamine-induced  desensitization also  was 
examined  (data  not  shown). Cells were either desensitized  for 
30 min  or desensitized  for 15  min  then  treated  with 0.25 mg/ 
ml of ConA in the continued presence of isoproterenol for 
another 15 min. After  incubation  with isoproterenol and 
ConA, the cultures were washed three times with Hepes- 
buffered  Eagle’s  medium at 37 “C  with  or  without ConA and 
incubated for an  additional 45 min at  37 “C.  There was no 
effect of ConA on  the  capacity of cells to recover catechol- 
amine-stimulated  adenylate cyclase activity  to  control levels 
or  on  the conversion of receptors back to  the  plasma mem- 
brane form.  A variety of other  agents were examined for their 
activity  as blockers of the  agonist-induced modification of the 
membrane form of the @-adrenergic receptor. Methylamine 
(1-100 mM), colchicine (0.1 mM), di-5-dimethylamino- 
naphthalene-1-sulfonyl  cadaverine (0.5 mM), and chloroquine 
(100 PM) all had  no effect on  the  agonist-induced  change  in 
the  gradient  distribution of receptors. 
The specificity of the  change  in  the  membrane form of 6- 
adrenergic  receptors was examined by determining  the  gra- 
dient  distribution of adenylate cyclase activity of lysates from 
control and desensitized cells (Fig. 5). Basal and isoproter- 
enol-, fluoride-, and fluoride + 0.03% Lubrol-PX-stimulated 
adenylate cyclase activities were measured  in pooled fractions 
from the  light  peak  and  from  the  plasma  membrane fraction. 
Although there was a 50% decrease in isoproterenol-stimu- 
lated adenylate cyclase activity in the plasma membrane 
This effect ofpreincubation  with ConA prior to incubation of cells 
with catecholamine  should not be confused  with the routine use of 
ConA in these experiments. That is, in all  experiments, ConA treat- 
ment of cells subsequent to agonist-induced  desensitization is used as 
a means of more effectively separating the light peak and plasma 
membrane  fractions  (10, 16, 17). 
TABLE I 
Activities of the components of adenylate cyclase in control and 
desensitized membrane fractions 
Membrane fraction“ P-Receptorb N.’ Cd 
fmollmg nrnol/rnin/mg nrnol/rnin/rng 
Control  light peak 14 0.33  0.20 
Control  plasma  membrane 118 1.59 2.66 
Desensitized light peak 60 0.38  0.21 
Desensitized plasma  mem- 69  1.49  2.38 
brane 
a Light and plasma membrane fractions were isolated from 27 
plates each of untreated  and desensitized  (20 min at  37 ”C with 1 PM 
isoproterenol) 1321N1 cells which had been grown to confluence. 
Pooled fractions were 1.39,  1.73,  0.89, and 1.24 mg/ml of protein for 
control  light peak and plasma  membrane and desensitized light peak 
and plasma  membrane  fractions, respectively. 
The density of @adrenergic  receptors was determined from Scat- 
chard  analyses of Iz5I-PIN binding to  the fractions. 
‘ The activity of N, was determined in extracts of the membrane 
fractions prepared as described under “Experimental Procedures.” 
Extracts were diluted with a solution containing (final concentra- 
tions) 20 mM Tris  (pH  8), 1 mM sodium/EDTA, 1 mM dithiothreitol, 
0.1% Lubrol-12A9, 10 mM MgClz, and 10 FM GTPrS  and incubated 
for 60 min a t  30 “C  to  activate N,. cyc- membranes were reconstituted 
with three dilutions of each extract,  and  the specific activity of N. 
was determined from these linear  reconstitutions of adenylate cyclase 
with added extract.  The activities  are expressed per mg  of the original 
membrane  protein. 
The activity of the catalytic  component of adenylate cyclase was 
determined by stimulation with a saturating concentration of purified 
rabbit liver N, which had been activated with GTPrS. Resultant 
adenylate cyclase activity was measured as described under  “Experi- 
mental  Procedures.” 
fraction,  no  increase  in  any  activity  parameter of adenylate 
cyclase occurred in  the  light  peak. However, assay of fluoride- 
stimulated  activity  in  the presence of 0.03% Lubrol-PX5 did 
‘ A  concentration-effect curve for the effects of Lubrol-PX on 
adenylate cyclase activity was generated for the light peak and  plasma 
membrane  fraction of gradients. An approximately 8-fold increase in 
basal or NaF-stimulated adenylate cyclase activity occurred in the 
presence of detergent in the light peak fractions. The optimal  con- 
centration for this effect was 0.03% Lubrol-PX. Only minor (-2-fold 
increase) effects of Lubrol-PX  on enzyme activity were observed in 
assays with the plasma  membrane  fraction. 
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FIG. 5. Adenylate cyclase activity 
in sucrose density gradient frac- 
tions generated from control and de- 
sensitized cells. Peak regions from two 
control (solid bars) and two desensitized 
(open bars) gradients were prepared as 
described in the legend to Fig. 2. Basal, 
isoproterenol ( IS0)- ,  NaF-, and  NaF + 
Lubrol-PX (0.03%)-stimulated adenyl- 
ate cyclase activities were measured in 
both the light peak and  the plasma mem- 
brane (heavy peak) preparation. Sam- 
ples were treated in the absence or pres- 
ence of detergent for 20 min on ice im- 
mediately prior to assay. The specific 
binding of ‘*’I-PIN was determined as 
described under “Experimental Proce- 
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FIG. 6. ADP-ribosylation of 1321N1 membrane  fractions. Light peak and plasma membrane fractions 
prepared from control or desensitized cells were ADP-ribosylated with [cx-~’P]NAD and IAP or cholera toxin as 
described under  “Experimental Procedures.” A ,  and SI are the active subunits of cholera toxin and IAP, respectively. 
Lanes 1-4 are autoradiograms of cholera toxin-labeled membranes exposed for 60 h (desensitized plasma mem- 
branes, desensitized light peak, control plasma membranes, and control light peak, respectively). In lanes 5-8, the 
samples also were labeled with IAP and autoradiograms were exposed for 6 h (desensitized plasma membranes, 
desensitized light peak, control plasma membranes, and control light peak, respectively). 52K, for example, 52,000 
daltons. 
uncover a significant amount of latent enzyme activity in  the 
light peak fraction from both  control and desensitized cells 
(Fig. 5). 
We also have examined the distribution of the components 
of adenylate cyclase in  the light  peak and plasma  membrane 
fractions from both control and desensitized cells. Table I 
presents the results of the  quantitative activities assayed for 
N, and C. These results, in contrast to those for the p- 
adrenergic receptor, show that  the specific activities of N, and 
C are identical in  membrane  fractions  prepared from control 
or desensitized cells. In both  control and desensitized cells, 
the specific activities of N. and C are 5-10-fold  lower in the 
light peak fraction than in the plasma membrane  fraction. 
We also attempted  to determine if desensitization involves 
a modification of  N, or Ni by examining the cholera toxin and 
IAP labeling patterns of membrane  fractions  prepared from 
control or desensitized cells. Fig. 6  presents an autoradiogram 
from such an experiment. All four membrane  fractions display 
the same pattern of labeling with cholera toxin or IAP. 
Cholera toxin labels predominantly 52,000-,  45,000-, and 
42,000-dalton substrates from these membranes, and  the in- 
tensity of labeling correlates well with the N. activities meas- 
ured in  reconstitution  assays with cyc- membranes. In  other 
preparations of 1321N1 cell membranes, the 42,000-dalton 
cholera toxin substrate was absent, suggesting that  it may be 
a proteolytic product of the 52,000- or 45,000-dalton substrate. 
The predominant IAP  substrate  in all four membrane frac- 
tions was a 41,000-dalton peptide, as seen by Katada  and Ui 
(36, 37) for C6 glioma cells. As with the cholera toxin sub- 
strates,  the  IAP  substrate does not appear to be enriched in 
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FIG. 7. Comparison of sucrose 
density gradient profiles of &adre- 
nergic and muscarinic cholinergic 
receptors. Sucrose density gradients 
were generated from lysates of control 
(0) and desensitized (A) 1321Nl cells (1 
FM isoproterenol; 20 min) as described 
under “Experimental Procedures.” The 
distribution of @-adrenergic receptors 
(left) was determined with “‘1-PIN, and 
the distribution of muscarinic receptors 
(r ight)  was determined with [3H]QNB. 
The data for t3H]QNB are representa- 
tive of three experiments. 
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FIG. 8. Gradient distribution of marker enzymes and 8- 
adrenergic receptors. A ,  the distribution of @-adrenergic receptors 
from control (0) uersus desensitized (0) cells (15 min; 1 pM isopro- 
terenol) was compared on a 15-30% sucrose continuous gradient 
topped with a  step of 5% sucrose (see “Experimental Procedures”). 
B, cells were preincubated for 15 min with 1 p~ isoproterenol, and 
the distribution of acid phosphatase (O), galactosyltransferase (A), 
and 8-adrenergic receptors (0) was assessed on the gradient described 
above. The per cent of total activity recovered in the pellet fractions 
was  30-45%  for galactosyltransferase and 20-30%  for acid phospha- 
tase. 
the desensitized light  peak  fraction  as  compared  with  control 
cells. 
Further evidence for the specificity of the isoproterenol- 
induced alteration  in  the  gradient  distribution of @-adrenergic 
receptors was provided by monitoring the fate of another 
membrane-bound  receptor,  the  muscarinic holinergic  recep- 
tor.  Under  conditions where 40-50% of the P-adrenergic re- 
ceptors were converted to the form appearing in the light 
peak,  no  change occurred in  the  density  gradient profile of 
Gradient Froction 
muscarinic receptors identified (38) by [3H]QNB binding (Fig. 
7).  
One interpretation of the  data  indicating a  change  in the 
membrane  form of &adrenergic receptors  during  incubation 
of 1321N1 cells with isoproterenol is  that  an agonist-induced 
internalization of the p-adrenergic receptor has occurred. 
Thus,  the  extent  to which  @-adrenergic receptors  in  the  altered 
membrane form co-migrated with markers for subcellular 
organelles  was  examined. The  distribution  on shallow  sucrose 
density  gradients of marker enzymes  for Golgi, endoplasmic 
reticulum,  and lysosomes was compared to  that of P-adrener- 
gic receptors  appearing  in  the  light peak. Lysates from cells 
previously incubated for 20 min with 1 PM isoproterenol were 
resolved on a 15-30% sucrose density  gradient. No apparent 
association of lZ5I-PIN binding activity with lysosomal en- 
zyme marker  activity (acid phosphatase) occurred (Fig. 8B). 
The  marker for endoplasmic reticulum (glucose 6-phospha- 
tase)  exhibited a distribution  similar  to  that of acid phospha- 
tase  on  these shallow gradients  and  thus does not  appear  to 
be associated with the light peak of P-receptors (data not 
shown). While  the majority of galactosyltransferase activity 
migrated at a different density, a small  amount of this  activity 
co-migrated with  the light  peak of P-adrenergic  receptors  (Fig. 
8B). 
One possible concern  in  interpreting  these  results  is  that p- 
adrenergic receptors in an altered membrane form might 
exhibit different densities depending upon the point in a 
process of internalization and cellular processing at which 
they were examined. However, the peak of 1251-PIN binding 
activity that occurred at  18-22% sucrose on the gradient 
illustrated  in Fig. 8 migrated at  the  same  density irrespective 
of the  time (5-60 min) of incubation with  isoproterenol (data 
not  shown). As illustrated  in Fig. 8 A ,  the @-adrenergic  recep- 
tors  from  control cells  did not  migrate as a distinct  peak,  but 
rather were broadly distributed throughout the 15-30% su- 
crose gradient. Adenylate cyclase activity  also  did not migrate 
as a distinct  peak  in  these  gradients  (data  not  shown). 
The results illustrated above were all obtained utilizing 
sucrose density gradients to resolve the altered membrane 
form of the @-adrenergic receptor from receptors associated 
with  the  plasma  membrane. On the basis of this difference  in 
density, the two receptor-containing fractions also can be 
resolved by differential  centrifugation. As is illustrated  in Fig. 
13906 Altered  Form of the  P-Adrenergic R c ptor
9A, the majority of @-adrenergic receptors  in  control  lysates 
were pelleted by a 10-min  centrifugation at 15,000 X g. This 
g-force ranged  from 10,000 to 15,000 X g in  four  experiments. 
In  contrast, while greater  than 50%  of the @-adrenergic  recep- 
tors  in lysates  from cells previously incubated (15 min) with 
isoproterenol were pelleted at   the same low centrifugation 
forces, the remaining receptors were only pelleted at  much 
greater forces (Fig. 9A). The force (30,000 to greater than 
50,000 x g) necessary  for sedimenting  in a 10-min  centrifu- 
gation  all of the @-adrenergic receptors in lysates  from  desen- 
sitized cells was  variable. This  result  is  not  surprising  due  to 
variations  in  the  amount of tissue/ml  in  these  experiments 
and inaccuracies inherent  in  this  type of experiment  with a 
preparative centrifuge. The data suggest that the altered 
membrane  form of the  receptors  in  lysates  from desensitized 
cells can be resolved from the  plasma  membrane form simply 
by differential centrifugation. This point is more directly 
assessed in Fig. 9B. Receptors  migrating  in  the  light peak and 
plasma  membrane  fractions from  desensitized cells were di- 
luted to equivalent concentrations ( “ 4 % )  of sucrose and 
subjected to differential centrifugation (Fig. 9B). Whereas 
receptors from the plasma membrane fraction were sedi- 
mented at  between 20,000 and 30,000 x g, the majority of 
0 IO 20 30 40 50 
g ( X IO+) 
FIG. 9. Differential centrifugation of B-adrenergic recep- 
tors. A, differential  centrifugation of lysates from control and desen- 
sitized cells. Five 150-mm dishes of 1321N1 cells were treated with 
(A and A) or without (0 and 0) 1 PM isoproterenol for 20 min a t  
37 “C. Cells were then  treated with ConA and lysed hypotonically as 
described under  “Experimental Procedures.” The lysate was made up 
to 11 ml with hypotonic buffer, and  1-ml aliquots were added to 10 
centrifuge tubes. Paired control and desensitized  samples were cen- 
trifuged for 10 min at  various forces (500-50,000 X g) in a  Beckman 
JA-21 rotor and J-21C  centrifuge. “’I-PIN binding was then measured 
in both pellets (open symbols) and  supernatants (closed symbols). The 
data are plotted as the per cent of activity recovered under each 
condition and are representative of five similar experiments. B,  
differential  centrifugation of receptors from the light peak and plasma 
membrane  fractions from desensitized cells. Cells were desensitized 
for 20 min with 1 PM isoproterenol. The cells were treated with ConA 
and lysed, and sucrose density  gradients were generated as described 
under “Experimental Procedures.” Peak  fractions from each  gradient 
were combined and diluted to approximately 4% sucrose with the 
buffer used in lZ5I-PIN binding  assays. Aliquots were then added to 
centrifuge tubes and centrifuged as  described in A of this figure. 
Plasma membrane  pellet (A), light peak pellet (O), plasma  membrane 
supernatant (A), and light peak supernatant (0) are plotted as a  per 
cent of specifically bound  lZ5I-PIN recovered in  the  supernatant  and 
pellet at  each centrifugation force. 
receptors in  the light peak  fraction were not  sedimented by a 
10-min  centrifugation at 50,000 X g. 
DISCUSSION 
The  results of the  present  study provide  evidence that  the 
early  phase of catecholamine-induced  desensitization of ade- 
nylate cyclase can be separated into at least two different 
reactions. On a  kinetic  basis,  “uncoupling” or loss of hormonal 
responsiveness  occurs earlier  than does formation of the  light 
peak fraction of @-adrenergic receptors. This conclusion is 
supported by the observation that treatment of cells with 
ConA prevents  formation of the  light  peak receptor fraction 
under  conditions where neither  the uncoupling  reaction nor 
the recovery reaction are measurably altered.  Thus,  the fol- 
lowing set of reactions  can be proposed as a working hypoth- 
esis  for the mechanism of receptor-specific,  agonist-induced 
desensitization  in 132 1N1 cells: 
where DARN,  PAR”,  PARLp, and PARL are  the  native, uncou- 
pled, light peak, and lost (1-4, 10) forms of the receptor, 
respectively, and A is a  receptor  agonist. 
The  observation  that  Reactions 1 and 2 are rapidly  revers- 
ible (3) and  that Reaction 3 is relatively slow in  the forward 
direction and very slow in the reverse  direction (3,4) provide 
an  explanation for the  similar  kinetics of loss of PARN and 
@ARLp during  continued exposure to isoproterenol (Fig. 1). In 
other words, conversion of a few molecules of  @ARLp to PARL 
would result  in a rapid  adjustment of the  steady  state levels 
of BARN, PARu, and PARLP; the consequence is the near 
parallel  rates of loss of PARN and @ARLp over an  11-h exposure 
to isoproterenol. 
The  results of the  present  study also  provide further evi- 
dence for the specificity of the agonist-induced, receptor- 
specific desensitization process. Isoproterenol causes  no 
movement of muscarinic cholinergic receptors to the light 
fractions of sucrose gradients.  In  addition,  adenylate cyclase 
activity is not observed to increase in the light peak after 
exposure to isoproterenol nor  are  its  components when they 
are assayed  directly. 
The presence of significant amounts of NaF-stimulated 
enzyme activity  in  the light  peak region of both  control  and 
desensitized gradients  is revealed by treatment of the samples 
with 0.03% Lubrol-PX. One interpretation of such  results is 
that  the  light peak region is  contaminated  with right side-out 
vesicle fragments of the  plasma  membrane. If such were the 
case, these vesicles would not have measurable adenylate 
cyclase activity since ATP would have  limited access to  the 
active site of the enzyme  within the vesicle. Lubrol would be 
expected to permeabilize the membrane to ATP. The fact 
that Lubrol  caused  a large increase (8-fold) in activity  in the 
light  peak but only a minor increase  (2-fold) in enzyme 
activity in  the heavy peak region (which contains primarily 
open sheets of plasma membrane) is consistent with this 
interpretation. 
The experimental results shown in Table I and Fig. 6 
indicate  that  no  detectable  transfer of  N, or Ni into  the light 
peak fractions occurs upon exposure of cells to isoproterenol. 
However, the results cannot exclude the possibility that a 
complex with a 1:l stoichiometric ratio of  N, to @-receptor is 
shifted  to  these fractions.  Based on our calculations, the N, 
content of the  light  peak  fractions of control  samples  (Table 
I) is about 580 fmol.6 About 70 fmol of @-receptor were 
Northup et al. (48) have determined that  the specific activity of 
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transferred to the  light  peak  fractions  during  desensitization. 
In view of the  potential  variation  in  estimates of N., it  seems 
unlikely that we could distinguish values  for N, of 580 and 
650 fmol before and after desensitization. In fact, in the 
experiment  shown  (Table  I), less N, was found  in  the  light 
peak  fractions  from  desensitized cells. This probably is pri- 
marily a reflection of a difference in  protein  content  since  the 
percentage of total N, in  the  light  fractions was the  same  in 
control and desensitized preparations, and, as shown, the 
specific activity of N, was  slightly  higher in  the desensitized 
sample. Stadel et al. (13) have  carried  out  similar  experiments 
using frog erythrocytes. They concluded that N, was not 
sequestered along with the @-receptor into a light vesicle 
fraction  during  desensitization.  The conclusion  was based  on 
a reconstitution  assay (22) for N, similar  to  that used in  our 
studies.  Their  results  indicate  that,  after  desensitization,  the 
vesicle fraction contains about 11% of the N, contained in 
the  plasma  membrane  fraction f control cells. The N, content 
of the vesicle fraction of control cells was not reported. 
Although Stadel et al. (13) did  not  report  sufficient  details  to 
allow us  to  make  the  calculation described  above, it is clear 
that the proportion of N, in light and heavy peaks after 
desensitization in either frog erythrocytes  or 1321Nl cells is 
low (11-14%) and that N, is not transferred to  the light 
vesicle fractions  in  proportion  to  the  per  cent  movement of 
@-receptors. However, it  is probable that  the  results from frog 
erythrocytes (13) need to be  accepted with  the  same  caveats 
as  indicated for the  results  with 1321N1 cells. 
The  studies of marker enzyme distribution failed to  dem- 
onstrate clear patterns of co-migration of the @ARw with  the 
Golgi apparatus, endoplasmic reticulum,  or lysosomes. How- 
ever, these  results  cannot unequivocally  exclude an  associa- 
tion of the agonist-modified receptors  with  any of these  or- 
ganelles. 
I t  is of interest  to  understand  the  nature of the  @-receptors 
that  appear  in  the  light  peak  fraction of control gradients. 
Based  on  an  estimate of plasma  membrane  contamination of 
the  light  peak,  it  can be predicted  that  no more than 10% of 
the  total  measurable  @-receptors  should  appear  in  this  fraction 
of gradients from control cells. In  fact, we routinely find 8- 
12% of the  total  @-receptors  in  the  light peak. This leads to 
the  somewhat  anomalous  set of observations  that  on  the  one 
hand all of the @-receptors in the light peak from control 
gradients  can be accounted  for by plasma  membrane  contam- 
ination, i.e. native @-receptors, but on the other hand we 
previously  observed that  these  receptors  exhibited  an  uncou- 
pled  behavior in agonist  competition  binding  studies (10). The 
lack of high affinity  binding of agonist  in  the  absence of GTP 
is a property we and  others have attributed  to  the uncoupled 
state of the  receptor  during  short-term  desensitization (1,  8, 
39). One possible explanation for this anomaly is that the 
contaminating plasma membrane fragments containing the 
receptor do not  contain N,, which is required for the  expres- 
sion of high affinity  binding of agonist. Ross et al. (15) have 
calculated that if the @-adrenergic receptor and adenylate 
cyclase components of S49 lymphoma cells were randomly 
and  independently  distributed  in  the  plasma  membrane,  then 
they  both  should  not be found  together  in  membrane frag- 
homogeneous preparations of rat liver N, range between 7 and 17 
pmol/min/mg of N, when assayed according to standard procedures 
the N. of 1321N1 cells, we have used the data  in Table I to calculate 
(22). Assuming a similar turnover  number and molecular weight for 
the amount of N, in light and heavy peak fractions from sucrose 
gradients. These values (based on a specific activity of 12 pmol/min/ 
mg of N.) are: control light peak, 582 pmol; control heavy peak, 3475 
pmol; desensitized light peak, 430 pmol; desensitized heavy peak, 
2380 pmol. 
ments of the size  observed in  their  studies. Also, Sahyoun et 
al. (40) observed that  fragmentation by sonication of mem- 
branes containing catecholamine-responsive adenylate cy- 
clase resulted  in a fraction of smaller membrane  fragments 
which contained  both @-adrenergic receptors  and  adenylate 
cyclase activity,  but  hormone responsiveness  was  lost.  Alter- 
natively, receptors involved in  transit  to  or  from  the  plasma 
membrane could contribute  to  this  fraction  that  no longer CO- 
migrates with  markers for the  plasma  membrane.  Indeed,  in 
contrast  to desensitized cells, the  receptors  in  the  light  frac- 
tions  from  control  gradients  exist as a rather  broad  band with 
little evidence of a distinct peak of activity (Fig. 8A), suggest- 
ing  that a heterogeneous set of receptor-containing  structures 
contributes  to  this activity. Thus,  the lack of high affinity 
binding of agonist and  guanine nucleotide  effects on  binding 
in the  light  peak  fraction from control cells could be due  to 
any of several factors  that would result  in a  lack of normal 
interaction of @-adrenergic  receptors and N.. 
We and most other workers in  this field have routinely 
utilized a 10-20-min centrifugation at 20,000-40,000 X g to 
prepare a membrane  fraction for the  determination of receptor 
levels during  catecholamine-induced  desensitization.  In  ret- 
rospect, this is a less than  optimal  practice  that  has a number 
of ramifications  in  relation  to  the  data  presented  in Fig. 9. 
Thus, receptors discussed as lost (degraded?) due to their 
failure to be detected  in a sedimented  membrane  fraction may 
in  fact be present  in a form such  as  that  in  the light  peak that 
does not  sediment  under  the given conditions for centrifuga- 
tion.  These  receptors might  indeed be “lost”  in a functional 
sense but could rapidly reattain  their  functional association 
with adenylate cyclase upon removal of catecholamine from 
the medium and  thus would be  distinguishable  from  receptors 
that were degraded or modified in a  long-lasting way. Varia- 
bilities in  time  and  other  conditions of centrifugation could 
lead to variabilities in the extent to which receptors were 
recovered in  the  sedimentable fraction. As pointed  out earlier,3 
we have observed  variabilities in  the loss of receptors at  early 
time  points of desensitization.  Stadel et al. (13) have reported 
recently that  essentially  all of the P-adrenergic receptors  that 
are  lost from a plasma  membrane  fraction  during  incubation 
of frog erythrocytes  with isoproterenol can be recovered in a 
sedimentable form by centrifugation at 158,000 x g. 
The  catecholamine-induced conversion of @-adrenergic re- 
ceptors  to  another  membrane form that  exhibits  properties 
similar  to  those observed  with 1321N1 cells has been reported 
for frog erythrocytes (11-13) and C6 rat glioma cells (41). 
Since the kinetics of occurrence of catecholamine-specific 
desensitization  are  remarkably  similar in these  three  systems, 
as well as  in a number of other cell types (5, 7-9), it  is likely 
that  the  phenomenon  studied  in  the  present  manuscript  rep- 
resents a generally occurring response of the @-adrenergic 
receptor  system to catecholamines. In analogy  with  polypep- 
tide  receptor  systems (42,431, the  source of the  altered  mem- 
brane form of the @-adrenergic  receptor would be  a  process of 
catecholamine-induced receptor  endocytosis.  Indeed, the  fact 
that catecholamines induce a rapid, selective conversion of 
the P-receptor to a form  that  sediments  during  centrifugation 
with characteristics  that clearly differentiate  it  from receptors 
bound  to large fragments of plasma  membrane  is difficult to 
explain by a  known mechanism  other  than endocytosis. 
Chuang  and  Costa (ll), Chuang et al. ( E ) ,  and  Stadel et al. 
(13) have  presented  arguments  in favor of the occurrence of 
agonist-induced endocytosis of the @-adrenergic receptor of 
frog erythrocytes.  Intact cell binding  assays with  desensitized 
1321N1 cells also suggest that,  during  short-term  incubation 
with catecholamines, receptors are rapidly sequestered in a 
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localization that is inaccessible to membrane-impermeable p- 21. Salomon, Y., Londos, C., and Rodbell, M. (1974) Anal. Biochem. 
adrenergic  receptor rad io ligand^.^ Similar results have been 58 ,  541-548 
obtained using glioma and lymphoma cells (44-46). 22. Sternweis, P. C., and Gilman, A. G. (1979) J. Biol. Chem. 254 ,  3333-3340 ~~~~ ~~~. 
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